Skip to content

Clinical trials

Phase 2/3 trials in Lebanon

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Lebanon Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20123
20142
20151
20161
20171
20182
20191
20202
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
American University of Beirut Medical Center4
Amgen2
Agios Pharmaceuticals, Inc.1
CSL Behring1
EMD Serono1
Janssen Research & Development, LLC1
Laboratoire français de Fractionnement et de Biotechnologies1
Lebanese American University1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease2
Homozygous Familial Hypercholesterolemia2
Hypercholesterolemia2
Hyperlipoproteinemia Type II2
Afibrinogenemia1
Anemia, Sickle Cell1
Dandruff1
Diabetes Mellitus1
Endometriosis1
Gastroesophageal Reflux1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.